Product Information
ONGENTYS 50 MG CAPSULE is a brand product labeled by Amneal Pharmaceuticals LLC, priced at $24.7603 per EA under NDC 64896040301. Its NADAC has been published 113 times since Aug 7, 2024.
FDA first approved this application on Apr 24, 2020.
Strength
50 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
64896040301
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OPICAPONEApproval Type
New Drug (NDA)
FDA Application
NDA212489FDA Approved
4/24/2020
On Market Since
4/5/2024
Pharmacological Classes
Price Statistics
The NADAC for ONGENTYS 50 MG CAPSULE has been published 113 times since Aug 7, 2024, and over the history we have for it it has risen 15.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24.7603 per EA |
|---|---|
| All-time high | $24.7764 (Jul 15, 2026) |
| All-time low | $21.4010 (Oct 23, 2024) |
| 52-week high | $24.7764 |
| 52-week low | $23.5602 |
| Median price | $23.5602 |
| Average price | $23.4885 |
| Largest weekly change | +9.9% (Jan 29, 2025) |
| Weeks tracked | 113 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the opicapone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
opicapone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Catechol-O-Methyltransferase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONGENTYS 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ONGENTYS 50 MG CAPSULE, manufactured by Amneal Pharmaceuticals LLC, is $24.7603 per EA (NDC 64896040301), effective Sep 30, 2026.
How has the price of ONGENTYS 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ONGENTYS 50 MG CAPSULE has risen 15.5%. It has been tracked across 113 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for ONGENTYS 50 MG CAPSULE?
Since Aug 7, 2024, the NADAC for ONGENTYS 50 MG CAPSULE has ranged from a low of $21.4010 (Oct 23, 2024) to a high of $24.7764 (Jul 15, 2026), with a median of $23.5602 per EA.
Are there cheaper alternatives to ONGENTYS 50 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ONGENTYS 50 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ONGENTYS 50 MG CAPSULE?
ONGENTYS 50 MG CAPSULE (NDC 64896040301) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a brand product.